Diagnostic utility of osteocalcin, undercarboxylated osteocalcin, and alkaline phosphatase for osteoporosis in premenopausal and postmenopausal women

Annals of Laboratory Medicine

Volumn 32, Issue 1, 2012, Pages 23-30

  Atalay, Sacide ^a   Elci, Abdullah ^b   Kayadibi, Huseyin ^c   Onder, Can B ^a   Aka, Nurettin ^a  

^a Haydarpasa Numune Teaching and Research Hospital   (Turkey)

^b ACIBADEM HOSPITAL   (Turkey)

^c Iskenderun Military Hospital   (Turkey)

Author keywords

Bone mineral density; Menopause; Osteocalcin; Osteoporosis; Undercarboxylated osteocalcin

Indexed keywords

EID: 84859611717     PISSN: 22343806     EISSN: 22343814     Source Type: Journal    
DOI: 10.3343/alm.2012.32.1.23     Document Type: Article

References (22)

1. NIH consensus development panel on osteoporosis prevention, diagnosis, and therapy, March 7-29, 2000: highlights of the conference. South Med J 2001;94:569-73.
2. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 1996;3:337-49. (Pubitemid 26076383)
3. Christiansen C and Lindsay R. Estrogens, bone loss and preservation. Osteoporos Int 1990;1:7-13.
4. Dalle Carbonare L, Giannini S. Bone microarchitecture as an important determinant of bone strength. J Endocrinol Invest 2004;27:99-105. (Pubitemid 38324728)
5. Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002;359:1929-36. (Pubitemid 34615775)
6. Sinaki M. Prevention and treatment of osteoporosis. In: Braddom RL. Ed. Physical medicine and rehabilitation, 3rd ed. Elsevier, Philadelphia: Elsevier, 2006:929-49.
7. Garnero P and Delmas PD. Biochemical markers of bone turnover. Applications for osteoporosis. Endocrinol Metab Clin North Am 1998;27: 303-23.
8. Allison JL, Stephen H, Richard E. Measurement of osteocalcin. Ann Clin Biochem 2000;37:432-46.
9. Swaminathan R. Biochemical markers of bone turnover. Clin Chim Acta 2001;313:95-105. (Pubitemid 33016697)
10. Aonuma H, Miyakoshi N, Hongo M, Kasukawa Y, Shimada Y. Low serum levels of undercarboxylated osteocalcin in postmenopausal osteoporotic women receiving an inhibitor of bone resorption. Tohoku J Exp Med 2009;218:201-5.
11. Vergnaud P, Garnero P, Meunier PJ, Bréart G, Kamihagi K, Delmas PD. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in eldery women: the EPIDOS study. J Clin Endocrinol Metab 1997;82:719-24. (Pubitemid 27106576)
12. Booth SL, Broe KE, Gagnon DR, Tucker KL, Hannan MT, McLean RR, et al. Vitamin K intake and bone mineral density in women and men. Am J Clin Nutr 2003;77:512-6. (Pubitemid 36133397)
13. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO study group. World Health Organ Tech Rep Ser 1994;943:1-129.
14. Sokoll LJ, O'Brien ME, Camilo ME, Sadowski JA. Undercarboxylated osteocalcin and development of a method to determine vitamin K status. Clin Chem 1995;41:1121-8.
15. Chailurkit LO, Ongphiphadhanakul B, Piaseu N, Saetung S, Rajatanavin R. Biochemical markers of bone turnover and response of bone mineral density to intervention in early postmenopausal women: an experience in a clinical laboratory. Clin Chem 2001;47:1083-8. (Pubitemid 32493595)
16. Ivaska KK, Hentunen TA, Vääräniemi J, Ylipahkala H, Pettersson K, Väänänen HK. Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro. J Biol Chem 2004;279: 18361-9. (Pubitemid 38623251)
17. Lindsay R. The menopause and osteoporosis. Obstet Gynecol 1996;87 (S2):S16-9.
18. Gnudi S, Mongiorgi R, Figus E, Bertocchi G. Evaluation of the relative rates of bone mineral content loss in postmenopause due to both estrogen deficiency and ageing. Boll Soc Ital Biol Sper 1990;66:1153-9.
19. Plantalech L, Guillaumont M, Vergnaud P, Leclercq M, Delmas PD. Impairment of gamma carboxylation of circulating osteocalcin (bone gla protein) in elderly women. J Bone Miner Res 1991;6:1211-6.
20. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 1993;91:1769-74. (Pubitemid 23127383)
21. Knapen MH, Nieuwenhuijzen Kruseman AC, Wouters RS, Vermeer C. Correlation of serum osteocalcin fractions with bone mineral density in women during the first 10 yr after menopause. Calcif Tissue Int 1998; 63:375-9. (Pubitemid 28476325)
22. Yasui T, Uemura H, Tomita J, Miyatani Y, Yamada M, Miura M, et al. Association of serum undercarboxylated osteocalcin with serum estradiol in pre-, peri- and early post-menopausal women. J Endocrinol Invest 2006;29:913-8. (Pubitemid 46165017)